ChiCTR-TRC-14004932
结束
/
/
/
2014-07-11
/
/
Neck pain
腹針治療頸痛的臨床隨機對照研究
腹針治療頸痛的臨床隨機對照研究
Abdominal acupuncture treatment under the guidance of traditional Chinese medicine acupuncture meridian theory and new concepts developed by Dr Ziyun Bo.
随机平行对照
Ⅳ期
Random
/
Pok Oi Hospital - The Chinese University of Hong Kong Chinese Medicine Centre for Training and Research (Shatin)
/
154
/
2014-09-01
1990-01-01
/
1. Between 18 and 65 years of age with the ability to speak and understand Cantonese; 2. Neck complaints on: (1) pain, stiffness or tenderness, with or without musculoskeletal signs including decreased range of motion and point tenderness; (2) pain felt in the neck with radiation to the occiput or towards the shoulders, or both with limitation of neck motion; and (3) neck pain with degenerative joint disease or cervical spondylosis, or both; 3. 3 points or more on a 10-cm visual analogue scale for neck pain at the time of screening; 4. No previous treatment with abdominal acupuncture for any reason; 5. Agreed to be randomized; and 6. Agreed to sign the informed consent form.;
请登录查看1. Visceral pain in the neck, including carcinoma of thyroid or larynx and tuberculosis of larynx; 2. Serious spinal disorders, including malignancy, vertebral fracture, spinal infection and inflammatory spondylitis; 3. Patients who previously had neck surgery or are scheduled to have one during the study; 4. Other chronic diseases that could interfere with abdominal acupuncture treatment effects, including cardiovascular disease, diabetic neuropathy, active hepatitis, fibromyalgia, rheumatoid arthritis, dementia and epilepsy; 5. Diagnosis of cancer of any nature; 6. Chief musculoskeletal pain other than neck pain; 7. Conditions that abdominal acupuncture might not be safe, including clotting disorders, administration of an anticoagulant agent, acute abdominal disorders, venous dilation of the naval, celiac tumor and pregnant women; 8. Possess abdominal scar which will affect the proper selection of acupuncture points for abdominal acupuncture; 9. Severe psychiatric or psychological disorder; 10. Acupuncture treatment for neck pain during the previous month; 11. Conflicting or ongoing co-interventions (drugs or alternative treatments, or both); 12. Engage in any other clinical trial during the study period; 13. Pending neck-related litigation or disability claims; 14. Incapacity to complete the questionnaires or to answer the questions of the assessor in the study; and 15. Pregnant and breast feeding women.;
请登录查看School of Chinese Medicine, 1/F Sino Building, The Chinese University of Hong Kong, N.T., Hong Kong
/
School of Chinese Medicine, 1/F Sino Building, The Chinese University of Hong Kong, N.T., Hong Kong的其他临床试验
The Chinese University of Hong Kong的其他临床试验
- Longitudinal and Moderating Effects of Repetitive Gain and Nonloss Framing on Self-Care, Digital Mental Health Platform Engagements, and Mental Health
- Feasibility, Acceptability and Effectiveness of a Tailored Multidimensional Intervention for Dementia Family Caregivers in Caregiving and Mental Health Crisis: A Pilot Randomised Controlled Trial
- One-step Rehydration Thawing Method in Frozen Embryo Transfer: A pragmatic randomized controlled clinical trial (ORT-FET-RCT)
- Feasibility and Acceptability of Cognitive Behavioural Stress Management Intervention (JoyMUM) for Pregnant Women: A Pilot Randomised Controlled Trial
- Building Resilience Against Rising Temperature - The Effect of High-Intensity Interval Exercise (HIIE) on Heat Tolerance, Thermoregulatory Adaptation, and Physical Fitness: A Comparative Randomized Controlled Trial
- The effect of Sodium-Glucose Cotransporter-2 Inhibitors and Dipeptidyl Peptidase-4 Inhibitors on Diabetic Retinal Disease
- 运动与脑刺激疗愈:促进居住于分间楼宇单位的注意力缺陷多动障碍儿童症状控制的三臂随机对照试验
- Effects of Care partner Online Programme for Managing BPSD and Enhancing Wellbeing (COPE‑BPSD)
- Air purifier and respiratory outcomes in childhood asthma in compromised housing environments: a hybrid effectiveness-implementation trial
- To investigate structural variations (SVs) in autism spectrum disorder (ASD) and related endophenotypes
- Young Adult Community Health Advisor (YACHA)-led Project to Promote Anti-drug Awareness among South Asian Youths and their Family in Hong Kong
- Effects of High-Intensity Interval Training on Physical Fitness, Cognitive and Mental Health in Hong Kong Adolescents with Intellectual Disabilities: A Cluster-Randomized Controlled Trial
- A self-determination theory-based interprofessional intervention to improve diabetes management in the primary health care setting of Hong Kong
- The Effects of Low‐ and High‐Glycemic Index Sport Nutrition Bars on Metabolism and High‐Intensity Interval Training Responses
- An innovative approach to combine intermittent dieting (INTD) with high-intensity interval exercise (HIIE) for curbing central obesity: A comparative randomized controlled trial
- Effectiveness of acceptance-based diabetes self-management (ACT-DSM) for adults with type 2 diabetes for improving diabetes distress and glycaemic control: A randomised controlled trial
- Effects of GABA with Butyrate, GABA/Butyrate-producing Synbiotics on Pain Relief in Fibromyalgia: A Phase II, Multi-Center, Double-Blinded, Randomized-Controlled Trial
- 一项关于声刺激增强慢波睡眠以改善失眠障碍睡眠质量的探索性研究
- The effects of art therapy-based intervention on anxiety children with haematological cancers: a randomised controlled trial
- Effectiveness of Digital CBT-I and BT-I combined ACT for Insomnia and Anxiety Symptoms in Youth: A Randomised Control Trial
最新临床资讯
-
一项5年临床安全随访研究启示:#脐带间充质干细胞(#hUC-MSCs)
SCLnow圣释2026-11-11
-
SYNCHRONIZE-CVOT试验达到主要终点,索弗度肽(survodutide)成为全球首个证实心血管安全性的胰高血糖素/GLP-1双受体激动剂
勃林格殷格翰中国2026-11-11
-
医药观澜2026-11-11
-
宜明昂科2026-11-11
-
医学科学院精准医学研究所2026-11-11
-
多肽圈2026-11-11
-
多肽圈2026-11-11
-
求是网2026-11-11
-
干细胞之父2026-11-11
-
和田维药2026-11-11
全球药物研发中心
全球研发数据与行业前沿情报
-
2026-11-12
-
2026-11-12
-
2026-11-12
-
摩熵咨询 20 3
-
摩熵咨询 33 60
-
摩熵咨询 20 3
-
颁布机构:国家卫生健康委办公厅、 2026-11-10
-
颁布机构:国家卫健委(原国家卫计委) 2026-11-10
-
颁布机构:国家药品审评中心(CDE) 2026-10-16
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
-
2026-11-11
-
2026-11-11
-
2026-11-11
-
摩熵咨询 35 92
-
摩熵咨询 28 74
-
摩熵咨询 34 49
-
颁布机构:国家市场监督管理总局 2026-11-07
-
颁布机构:国家市场监督管理总局 2026-11-07
-
颁布机构:国家市场监督管理总局 2026-11-04

